Impaired mRNA Based COVID-19 Vaccine Response in Patients with B-Cell Malignancies after CD19 Directed CAR-T Cell Therapy

MLA

Nancy M. Hardy, et al. “Impaired MRNA Based COVID-19 Vaccine Response in Patients with B-Cell Malignancies after CD19 Directed CAR-T Cell Therapy.” Blood, vol. 138, Dec. 2021, p. 1738. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ec820a1038055cbb456d5f9189faca21&authtype=sso&custid=ns315887.

APA

Nancy M. Hardy, Kim G. Hankey, Seung Tae Lee, Aaron P. Rapoport, Mehmet Hakan Kocoglu, Nancy Smith, Tim Luetkens, Patricia Lesho, Sherri Bauman, Djordje Atanackovic, Jean A. Yared, Kathleen Ruehle, John W Baddley, Philip Margiotta, Stephanie Avila, Jennie Y. Law, & Saurabh Dahiya. (2021). Impaired mRNA Based COVID-19 Vaccine Response in Patients with B-Cell Malignancies after CD19 Directed CAR-T Cell Therapy. Blood, 138, 1738.

Chicago

Nancy M. Hardy, Kim G. Hankey, Seung Tae Lee, Aaron P. Rapoport, Mehmet Hakan Kocoglu, Nancy Smith, Tim Luetkens, et al. 2021. “Impaired MRNA Based COVID-19 Vaccine Response in Patients with B-Cell Malignancies after CD19 Directed CAR-T Cell Therapy.” Blood 138 (December): 1738. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ec820a1038055cbb456d5f9189faca21&authtype=sso&custid=ns315887.